Company Overview of Immunocore Limited
Immunocore Limited, a bio-technology company, discovers and develops bio-therapeutics for the treatment of cancer, viral diseases, and autoimmune diseases. It offers T cell receptors, a peptide antigen that presented on the surface of cells by human leukocyte antigen molecules; and IMCgp100, a novel bi-specific immunotherapeutic for the treatment of malignant melanoma. Immunocore Limited was formerly known as Avidex Limited and changed its name to Immunocore Limited in October 2008. The company was founded in 1999 and is based in Abingdon, United Kingdom.
91 Park Drive
Abingdon, OX14 4RY
Founded in 1999
44 12 3543 8600
44 12 3543 8601
Key Executives for Immunocore Limited
Immunocore Limited Key Developments
Similar Private Companies By Industry
|Cell Therapy Limited||Europe|
|Cambridge Molecular Technologies Ltd.||Europe|
|DestiNA Genomics Ltd||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Immunocore Limited, please visit www.immunocore.com. Company data is provided by Capital IQ. Please use this form to report any data issues.